Paving the road for the study of epigenetics in neurodegenerative diseases Oscar HarariCarlos Cruchaga Editorial 08 September 2016 Pages: 483 - 485
ALS and FTD: an epigenetic perspective Veronique V. BelzilRebecca B. KatzmanLeonard Petrucelli Review 09 June 2016 Pages: 487 - 502
The epigenome in Alzheimer’s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism Hans-Ulrich KleinDavid A. BennettPhilip L. De Jager Review 29 August 2016 Pages: 503 - 514
Epigenetic regulation in Parkinson’s disease Catherine LabbéOswaldo Lorenzo-BetancorOwen A. Ross Review 29 June 2016 Pages: 515 - 530
Neuropathological criteria of anti-IgLON5-related tauopathy Ellen GelpiRomana HöftbergerGabor G. Kovacs Original Paper Open access 29 June 2016 Pages: 531 - 543
The phosphatase calcineurin regulates pathological TDP-43 phosphorylation Nicole F. LiachkoAleen D. SaxtonBrian C. Kraemer Original Paper 29 July 2016 Pages: 545 - 561
ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamics Jozsef GalLisha KuangHaining Zhu Original Paper Open access 01 August 2016 Pages: 563 - 576
Human-to-mouse prion-like propagation of mutant huntingtin protein Iksoo JeonFrancesca CicchettiJihwan Song Original Paper Open access 24 May 2016 Pages: 577 - 592
Towards authentic transgenic mouse models of heritable PrP prion diseases Joel C. WattsKurt GilesStanley B. Prusiner Original Paper 28 June 2016 Pages: 593 - 610
PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions Rona M. BarronDeclan KingPedro Piccardo Original Paper Open access 04 July 2016 Pages: 611 - 624
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort Emeline TabouretAnh Tuan NguyenFor POLA Network Original Paper 29 August 2016 Pages: 625 - 634
Evidence of H3 K27M mutations in posterior fossa ependymomas Marco GessiDavid CapperDominik Sturm Correspondence 18 August 2016 Pages: 635 - 637